Hepatitis B Diagnostic Tests Market: Notable Developments & Geographical Outlook

Future Market Insights presents a new report titled ‘Hepatitis B Diagnostic Tests Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2022 – 2028’ that studies the performance of the global hepatitis B diagnostic tests market over a 6 year assessment period from 2022 to 2028. The report presents the value forecasts of the global hepatitis B diagnostic tests market and provides pertinent insights into the factors driving market growth as well as the factors restricting market growth. As per the figures provided by Future Market Insights, the global hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 872.5 Mn in 2022 and is likely to reach a valuation of nearly US$ 1,26 Bn in 2028 and in the process exhibit a CAGR of 6.4% during the period of forecast 2022-2028.

High Prevalence of Hepatitis B in the APEJ Region Boosting Global Market Revenue Growth

The prevalence of hepatitis B is highest in the APEJ region and the disease burden caused by chronic cases of hepatitis B is enormous. APEJ region has more number of chronic hepatitis B patients than any other region in the world and is thus a potential market for hepatitis B test kit manufacturers. As per the data provided by WHO, China accounts for one-third of all chronic hepatitis B infections. In addition, 6.2% of the adult population in the Western Pacific region is infected with hepatitis B. In the South-East Asia region, an estimated 2% of the general population is infected with hepatitis B. According to Hepatitis Australia, approximately 225,000 people are living with chronic hepatitis B in the country. As per the data provided by WHO, in India, the prevalence of hepatitis B surface antigen is 3%-4.2% with over 40 million hepatitis B carriers. Due to such high prevalence of hepatitis B in the APEJ region, the market for hepatitis B diagnostic tests has a huge potential in the region.

Global Hepatitis B Diagnostic Tests Market: Segmentation and Forecast

The global hepatitis B diagnostic tests market is segmented on the basis of product type, end user and region.

  • On the basis of product type, the enzyme immunoassay kits segment was estimated to be valued at nearly US$ 590 Mn in the year 2022 and is likely to reach a valuation of nearly US$ 1,100 Mn in 2028, accounting for a CAGR of 6.2% during the assessment period 2022-2028.
  • On the basis of end user, the hospitals segment was estimated to be valued at nearly US$ 250 Mn in 2022 and is estimated to reach a valuation of nearly US$ 460 Mn in 2028, registering a CAGR of 6.1% during the period of assessment.
  • On the basis of region, the APEJ hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 200 Mn in 2022 and is likely to reach a valuation of nearly US$ 380 Mn in 2028, accounting for a CAGR of 7.2% during the period of forecast.

Global Hepatitis B Diagnostic Tests Market: Competitive Landscape

This report features some of the important players functioning in the global hepatitis B diagnostic tests market such as bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience, Inc., Vista Diagnostics International, Biogate Laboratories Ltd., J.Mitra & Co. Ltd., Siemens Medical Solutions USA, Inc. and General Biologicals Corporation.

Browse More Details@ https://www.futuremarketinsights.com/reports/hepatitis-b-diagnostic-test-market

Comments

Post a Comment

Popular posts from this blog

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Cognitive Diagnostics Market Projected to Reach Unprecedented Growth by 2033

Image
As per Future Market Insights latest industry analysis, the valuation for the global  Cognitive Diagnostics market sales  is estimated to reach US$ 110.2 Billion in 2023 and is projected to exhibit a CAGR of 8.0% over the forecast period, with an estimated valuation of US$ 238.3 Billion by 2033. Several causes of brain problems or cognitive disorders include closed head injuries, contact with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on the area of the brain that is impacted, a person may have a certain form of cognitive problem. Communication issues could result from, for instance, a tumour in the speech cisterns of the brain. In another illustration, a brain infection that affects the motor recentres would cause problems with movement. Ageing is also a factor in the development of cognitive problems. Cognitive diagnostics increasingly use digital health technologies like wearables and smartphone apps. These tools can monitor a pati...
Read more